Amundi Raises Position in ICU Medical, Inc. (NASDAQ:ICUI)

Amundi lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 196.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,736 shares of the medical instruments supplier's stock after purchasing an additional 8,436 shares during the quarter. Amundi owned 0.05% of ICU Medical worth $2,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Arizona State Retirement System lifted its stake in ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after acquiring an additional 65 shares during the period. Equitable Trust Co. grew its position in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares during the period. Gagnon Securities LLC raised its stake in ICU Medical by 0.5% during the 4th quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after buying an additional 137 shares during the last quarter. Wealthspire Advisors LLC lifted its holdings in shares of ICU Medical by 6.4% during the 4th quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock valued at $413,000 after buying an additional 160 shares during the period. Finally, State of New Jersey Common Pension Fund D boosted its stake in shares of ICU Medical by 1.6% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 12,370 shares of the medical instruments supplier's stock worth $1,919,000 after buying an additional 191 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

ICU Medical Stock Performance

Shares of ICUI stock traded down $1.02 during trading hours on Friday, reaching $147.07. 563,328 shares of the company traded hands, compared to its average volume of 256,920. The firm has a 50-day moving average price of $156.22 and a 200 day moving average price of $164.53. The company has a market cap of $3.61 billion, a P/E ratio of -32.18 and a beta of 0.73. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Activity

In other news, CEO Vivek Jain sold 1,373 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 6.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ICUI. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price on the stock in a report on Wednesday, December 11th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Tuesday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.